to-BBB receives International Innovation grant to support partnership with top-5 pharma company

22-Dec-2011 - Netherlands

to-BBB has been awarded a grant of over €600,000 through the “Internationaal Innoveren” program of the Dutch government agency Agentschap NL to support a brain drug delivery partnership with a top-5 pharma company. This work will facilitate future license deals with to-BBB’s brain cancer product 2B3-101 as well as other therapies in the pipeline.

Willem van Weperen, CEO of to-BBB, says: “This research program will increase the chances of successful development of novel drugs for brain diseases by to-BBB in partnership with pharma companies. The financial support by Agentschap NL of more than €600,000 will accelerate to-BBB’s development programs and consolidate its role as a leading company in the area of brain drug delivery.” 

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance